Back

The dual endothelin-1 antagonist aprocitentan alleviates mitochondrial oxidative stress in human cardiac fibroblasts

European Heart Journal - Cardiovascular Pharmacotherapy

8 July 2024
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY HYPERTENSION BASIC SCIENCE

Contributors

Fahimeh Varzideh
Fahimeh Varzideh

Author

Stanislovas S Jankauskas
Stanislovas S Jankauskas

Author

Urja Jain
Urja Jain

Author

Lauren Soderquist
Lauren Soderquist

Author

Esther Densu Agyapong
Esther Densu Agyapong

Author

Urna Kansakar
Urna Kansakar

Author

Gaetano Santulli
Gaetano Santulli

Author

Montefiore Medical Center Albert Einstein College of Medicine New York , United States of America

You may be interested in
thumbnail
Congress Presentation
Hypertension, diabetes, and the kidney: a triple threat for adverse cardiovascular events?
thumbnail
Congress Presentation
Trend in the prevalence, awareness, treatment and control of hypertension among adult over in Nigeria over a 4-year period
thumbnail
Congress Presentation
Treadmill exercise test as a screening tool in the development of hypertension

ESC 365 is supported by

novartis Explore sponsored resources